Literature DB >> 12928150

Genetic variation in genes associated with arsenic metabolism: glutathione S-transferase omega 1-1 and purine nucleoside phosphorylase polymorphisms in European and indigenous Americans.

Lizhi Yu1, Kelly Kalla, Erin Guthrie, Amy Vidrine, Walter T Klimecki.   

Abstract

Individual variability in human arsenic metabolism has been reported frequently in the literature. This variability could be an underlying determinant of individual susceptibility to arsenic-induced disease in humans. Recent analysis revealing familial aggregation of arsenic metabolic profiles suggests that genetic factors could underlie interindividual variation in arsenic metabolism. We screened two genes responsible for arsenic metabolism, human purine nucleoside phosphorylase (hNP), which functions as an arsenate reductase converting arsenate to arsenite, and human glutathione S-transferase omega 1-1 (hGSTO1-1), which functions as a monomethylarsonic acid (MMA) reductase, converting MMA(V) to MMA(III), to develop a comprehensive catalog of commonly occurring genetic polymorphisms in these genes. This catalog was generated by DNA sequencing of 22 individuals of European ancestry (EA) and 24 individuals of indigenous American (IA) ancestry. In (Italic)hNP(/Italic), 48 polymorphic sites were observed, including 6 that occurred in exons, of which 1 was nonsynonymous (G51S). One intronic polymorphism occurred in a known enhancer region. In hGSTO1-1, 33 polymorphisms were observed. Six polymorphisms occurred in exons, of which 4 were nonsynonymous. In contrast to hNP, in which the IA group was more polymorphic than the EA group, in hGSTO1-1 the EA group was more polymorphic than the IA group, which had only 1 polymorphism with a frequency > 10%. Populations representing genetic admixture between the EA and IA groups, such as Mexican Hispanics, could vary in the extent of polymorphism in these genes based upon the extent of admixture. These data provide a framework in which to conduct genetic association studies of these two genes in relevant populations, thereby allowing hNP and hGSTO1-1 to be evaluated as potential susceptibility genes in human arsenicism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928150      PMCID: PMC1241635          DOI: 10.1289/ehp.6420

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  34 in total

1.  Artemis: sequence visualization and annotation.

Authors:  K Rutherford; J Parkhill; J Crook; T Horsnell; P Rice; M A Rajandream; B Barrell
Journal:  Bioinformatics       Date:  2000-10       Impact factor: 6.937

2.  The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus.

Authors:  S A Tishkoff; A J Pakstis; G Ruano; K K Kidd
Journal:  Am J Hum Genet       Date:  2000-06-19       Impact factor: 11.025

Review 3.  Role of oxidative damage in arsenic-induced teratogenesis.

Authors:  E S Hunter
Journal:  Teratology       Date:  2000-10

4.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

Authors:  B Ewing; L Hillier; M C Wendl; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

5.  A comparison of linkage disequilibrium measures for fine-scale mapping.

Authors:  B Devlin; N Risch
Journal:  Genomics       Date:  1995-09-20       Impact factor: 5.736

6.  PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.

Authors:  D A Nickerson; V O Tobe; S L Taylor
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

7.  Identification, characterization, and crystal structure of the Omega class glutathione transferases.

Authors:  P G Board; M Coggan; G Chelvanayagam; S Easteal; L S Jermiin; G K Schulte; D E Danley; L R Hoth; M C Griffor; A V Kamath; M H Rosner; B A Chrunyk; D E Perregaux; C A Gabel; K F Geoghegan; J Pandit
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

8.  Intron requirement for expression of the human purine nucleoside phosphorylase gene.

Authors:  J J Jonsson; M D Foresman; N Wilson; R S McIvor
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

9.  Lack of methylation of inorganic arsenic in the chimpanzee.

Authors:  M Vahter; R Couch; B Nermell; R Nilsson
Journal:  Toxicol Appl Pharmacol       Date:  1995-08       Impact factor: 4.219

10.  An enhancer in the first intron of the human purine nucleoside phosphorylase-encoding gene.

Authors:  J J Jonsson; A Converse; R S McIvor
Journal:  Gene       Date:  1994-03-25       Impact factor: 3.688

View more
  13 in total

1.  Novel folding and stability defects cause a deficiency of human glutathione transferase omega 1.

Authors:  Huina Zhou; Joseph Brock; Marco G Casarotto; Aaron J Oakley; Philip G Board
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

2.  Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism.

Authors:  Molly L Kile; E Andres Houseman; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mahiuddin; Golam Mostofa; Yu-Mei Hsueh; David C Christiani
Journal:  J Indian Soc Agric Stat       Date:  2013-08-01

3.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

4.  Interaction between arsenic exposure from drinking water and genetic susceptibility in carotid intima-media thickness in Bangladesh.

Authors:  Fen Wu; Farzana Jasmine; Muhammad G Kibriya; Mengling Liu; Xin Cheng; Faruque Parvez; Rachelle Paul-Brutus; Rina Rani Paul; Golam Sarwar; Alauddin Ahmed; Jieying Jiang; Tariqul Islam; Vesna Slavkovich; Tatjana Rundek; Ryan T Demmer; Moise Desvarieux; Habibul Ahsan; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2014-03-02       Impact factor: 4.219

5.  Association of glutathione S-transferase omega gene polymorphisms with progression of head and neck cancer.

Authors:  S Sanguansin; S Petmitr; P O-Charoenrat; W Pongstaporn
Journal:  Mol Biol Rep       Date:  2012-10-20       Impact factor: 2.316

6.  Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.

Authors:  Jennifer L Beebe-Dimmer; Priyanka T Iyer; Jerome O Nriagu; Greg R Keele; Shilpin Mehta; Jaymie R Meliker; Ethan M Lange; Ann G Schwartz; Kimberly A Zuhlke; David Schottenfeld; Kathleen A Cooney
Journal:  Environ Health       Date:  2012-06-29       Impact factor: 5.984

7.  Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children.

Authors:  Maria Mercedes Meza; Lizhi Yu; Yelitza Y Rodriguez; Mischa Guild; David Thompson; A Jay Gandolfi; Walter T Klimecki
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

8.  Genetic variants associated with arsenic susceptibility: study of purine nucleoside phosphorylase, arsenic (+3) methyltransferase, and glutathione S-transferase omega genes.

Authors:  Sujata De Chaudhuri; Pritha Ghosh; Nilendu Sarma; Papiya Majumdar; Tanmoy Jyoti Sau; Santanu Basu; Susanta Roychoudhury; Kunal Ray; Ashok K Giri
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

Review 9.  Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks.

Authors:  Paul Mushak
Journal:  Environ Health Perspect       Date:  2007-01-04       Impact factor: 9.031

10.  Polymorphisms of Glutathione S-transferases Omega-1 among ethnic populations in China.

Authors:  Songbo Fu; Jie Wu; Feng Chen; Dianjun Sun; Songbin Fu
Journal:  BMC Genet       Date:  2008-04-10       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.